NEW YORK (GenomeWeb) – Metabolon announced that it is partnering with Geisinger Medical Center in Danville, Pa., on a pilot study to evaluate Metabolon's Quantose IR test in monitoring glycemic control in people with prediabetes.

The study will monitor prediabetic subjects over a 12-week period using the Quantose IR test and evaluate hemoglobin A1c and fasting plasma glucose results. Participants in the study will receive metformin treatment and also will be on a regiment of diet and exercise.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.